Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis

Leukemia
A MatsuokaKaoru Tohyama

Abstract

Myelodysplastic syndromes (MDS) are a group of hematopoietic stem cell disorders characterized by refractory cytopenias and susceptibility to leukemic transformation. On a subset of MDS patients with deletion of the long arm of chromosome 5 (del(5q)), lenalidomide exerts hematological and cytogenetic effects, but the underlying pharmacological mechanisms are not fully understood. In this study, we have investigated the in vitro effects of lenalidomide on an MDS-derived cell line, MDS-L, which carries del(5q) and complex chromosome abnormalities. We found that the growth of MDS-L cells was specifically suppressed mainly by apoptosis, and in addition, multinucleated cells were frequently formed and finally died out in the presence of lenalidomide. Time-lapse microscopic observation and the DNA ploidy analysis revealed that lenalidomide does not affect DNA synthesis but inhibits cytokinesis of MDS-L cells. The gene expression profile showed decreased expression of M phase-related genes such as non-muscle myosin heavy-chain 10, polo-like kinase 1, aurora kinase B, citron kinase and kinesin family member 20A(KIF20A). Interestingly, KIF20A is located at 5q31. These data contribute to the understanding of action mechanisms of lenalido...Continue Reading

References

May 26, 1999·The New England Journal of Medicine·M L Heaney, D W Golde
Jul 1, 1999·Bioorganic & Medicinal Chemistry Letters·G W MullerD I Stirling
Apr 3, 2001·Molecular and Cellular Biology·R D FontijnA J Horrevoets
May 22, 2001·Molecular Biology of the Cell·P R AndreassenR L Margolis
Oct 20, 2001·Best Practice & Research. Clinical Haematology·H J Olney, M M Le Beau
May 31, 2002·Blood·Jacqueline BoultwoodJames S Wainscoat
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Peter H SchaferDavid I Stirling
Mar 19, 2005·Science·Michael Glotzer
Apr 28, 2005·Current Biology : CB·Annika GuseMichael Glotzer
Oct 4, 2006·International Journal of Cancer. Journal International Du Cancer·Erich A Nigg
Oct 6, 2006·The New England Journal of Medicine·Alan ListUNKNOWN Myelodysplastic Syndrome-003 Study Investigators
Jun 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Andrea PellagattiEva Hellström-Lindberg
Nov 6, 2007·Cell·Neil J Ganem, David Pellman
Jan 19, 2008·Nature·Benjamin L EbertTodd R Golub
Aug 1, 2008·Leukemia·T TasakaUNKNOWN Japanese Cooperative Study Group for Intractable Bone Marrow Diseases
Nov 26, 2008·Cancer Genetics and Cytogenetics·Claudia HaferlachAlan List
Apr 7, 2009·Leukemia Research·Hans G DrexlerRoderick A F Macleod
May 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sheng WeiAlan List

❮ Previous
Next ❯

Citations

Dec 14, 2011·Hematology·Lionel Adès, Pierre Fenaux
Oct 22, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shucheng GuXiao Li
Mar 15, 2014·Annals of Hematology·Mahmoud R Gaballa, Emmanuel C Besa
Dec 12, 2013·Leukemia·G W RhyasenD T Starczynowski
Oct 15, 2010·Expert Review of Anticancer Therapy·Carla HeiseRajesh Chopra
Oct 23, 2012·Experimental Hematology·Takayuki TsujiokaKaoru Tohyama
Jun 19, 2012·Experimental Hematology·Manja WobusUwe Platzbecker
Sep 29, 2012·British Journal of Haematology·Rastislav Horos, Marieke von Lindern
Nov 17, 2012·Clinical Lymphoma, Myeloma & Leukemia·Roberto CastelliMassimo Cugno
Jul 13, 2013·Cancer Cell·Garrett W RhyasenDaniel T Starczynowski
Nov 15, 2014·Leukemia·E BulychevaU Platzbecker
Aug 3, 2016·Cancer Immunology, Immunotherapy : CII·Kristoffer SandAstrid Olsnes Kittang
Nov 1, 2017·Antioxidants & Redox Signaling·Dustin Carroll, Daret K St Clair
Dec 17, 2014·Clinical Medicine Insights. Blood Disorders·Hani NakhoulHua Lu
Sep 6, 2018·International Journal of Hematology·Hiroyuki MoritaYumi Tohyama
Sep 19, 2018·Scientific Reports·Antònia Banús-MuletRuth M Risueño
Jun 29, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alejandro M GomezMario Losen
May 28, 2019·International Journal of Hematology·Kanae SakakibaraKaoru Tohyama
Apr 7, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angel Y F KamPhuong L Doan
Jan 28, 2021·Scientific Reports·Naohito FujishimaMakoto Hirokawa
Dec 3, 2020·International Journal of Molecular Sciences·Pavlína JanovskáVítězslav Bryja
Mar 10, 2021·British Journal of Haematology·Sahba ShafieeEmmet McCormack

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.